Loading clinical trials...
Loading clinical trials...
The goal of this observational study is to evaluate the safety and effectiveness of a home-monitoring device (RespirAI) in the early detection of COPD exacerbations in adults (age \>21) with physician...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
RespirAI US Inc
NCT05825014 · COPD Exacerbation
NCT07351929 · COPD Exacerbation
NCT05958563 · Sleep Apnea, COPD Exacerbation, and more
NCT06347536 · COPD, COPD Exacerbation
NCT03564236 · COPD Exacerbation
Methodist Physicians Clinic
Omaha, Nebraska
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions